BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 28087207)

  • 1. Continuous Medication Monitoring (CoMM): A foundational model to support the clinical work of community pharmacists.
    Goedken AM; Butler CM; McDonough RP; Deninger MJ; Doucette WR
    Res Social Adm Pharm; 2018 Jan; 14(1):106-111. PubMed ID: 28087207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of pharmacist-provided medication therapy management (MTM) services in community pharmacies over 7 years.
    Barnett MJ; Frank J; Wehring H; Newland B; VonMuenster S; Kumbera P; Halterman T; Perry PJ
    J Manag Care Pharm; 2009; 15(1):18-31. PubMed ID: 19125547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacists' performance of clinical interventions during adherence support medication reviews.
    Hatah E; Tordoff J; Duffull SB; Braund R
    Res Social Adm Pharm; 2014; 10(1):185-94. PubMed ID: 23688540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The medication experience: preliminary evidence of its value for patient education and counseling on chronic medications.
    Shoemaker SJ; Ramalho de Oliveira D; Alves M; Ekstrand M
    Patient Educ Couns; 2011 Jun; 83(3):443-50. PubMed ID: 21435815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiretroviral therapy adherence, medication use, and health care costs during 3 years of a community pharmacy medication therapy management program for Medi-Cal beneficiaries with HIV/AIDS.
    Hirsch JD; Gonzales M; Rosenquist A; Miller TA; Gilmer TP; Best BM
    J Manag Care Pharm; 2011 Apr; 17(3):213-23. PubMed ID: 21434698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Innovative Canadian Pharmacogenomic Screening Initiative in Community Pharmacy (ICANPIC) study.
    Papastergiou J; Tolios P; Li W; Li J
    J Am Pharm Assoc (2003); 2017; 57(5):624-629. PubMed ID: 28689706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the first year of a pilot program in community pharmacy: HIV/AIDS medication therapy management for Medi-Cal beneficiaries.
    Hirsch JD; Rosenquist A; Best BM; Miller TA; Gilmer TP
    J Manag Care Pharm; 2009; 15(1):32-41. PubMed ID: 19125548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perceptions of patients on Medicare Part D medication therapy management services.
    Truong HA; Layson-Wolf C; de Bittner MR; Owen JA; Haupt S
    J Am Pharm Assoc (2003); 2009; 49(3):392-8. PubMed ID: 19443319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How pharmacists check the appropriateness of drug therapy? Observations in community pharmacy.
    Nusair MB; Guirguis LM
    Res Social Adm Pharm; 2017; 13(2):349-357. PubMed ID: 27102265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacy performance while providing continuous medication monitoring.
    Doucette WR; McDonough RP; Herald F; Goedken A; Funk J; Deninger MJ
    J Am Pharm Assoc (2003); 2017; 57(6):692-697. PubMed ID: 28844583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implementation of targeted medication adherence interventions within a community chain pharmacy practice: The Pennsylvania Project.
    Bacci JL; McGrath SH; Pringle JL; Maguire MA; McGivney MS
    J Am Pharm Assoc (2003); 2014; 54(6):584-93. PubMed ID: 25379980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proactive pharmaceutical care interventions decrease patients' nonadherence to osteoporosis medication.
    Stuurman-Bieze AG; Hiddink EG; van Boven JF; Vegter S
    Osteoporos Int; 2014 Jun; 25(6):1807-12. PubMed ID: 24570297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medication therapy management in pharmacy practice: core elements of an MTM service model (version 2.0).
    ;
    J Am Pharm Assoc (2003); 2008; 48(3):341-53. PubMed ID: 18595820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implementing a pharmacist-led in-home medication coaching service via community-based partnerships.
    Akers JL; Meer G; Kintner J; Shields A; Dillon-Sumner L; Bacci JL
    J Am Pharm Assoc (2003); 2019; 59(2):243-251. PubMed ID: 30638730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacogenomics in a community pharmacy: ACT now.
    Padgett L; O'Connor S; Roederer M; McLeod H; Ferreri S
    J Am Pharm Assoc (2003); 2011; 51(2):189-93. PubMed ID: 21382809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A structured patient identification model for medication therapy management services in a community pharmacy.
    Pagano GM; Groves BK; Kuhn CH; Porter K; Mehta BH
    J Am Pharm Assoc (2003); 2017; 57(5):619-623.e1. PubMed ID: 28733156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized controlled study of practice facilitation to improve the provision of medication management services in Alberta community pharmacies.
    Houle SK; Charrois TL; Faruquee CF; Tsuyuki RT; Rosenthal MM
    Res Social Adm Pharm; 2017; 13(2):339-348. PubMed ID: 27017157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Community pharmacists' prescription intervention practices--exploring variations in practice in Norwegian pharmacies.
    Mandt I; Horn AM; Ekedahl A; Granas AG
    Res Social Adm Pharm; 2010 Mar; 6(1):6-17. PubMed ID: 20188324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of pharmacy practice on community pharmacists' integration of medication and lab value information from electronic health records.
    Hughes CA; Guirguis LM; Wong T; Ng K; Ing L; Fisher K
    J Am Pharm Assoc (2003); 2011; 51(5):591-8. PubMed ID: 21896456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A patient-centered pharmacy services model of HIV patient care in community pharmacy settings: a theoretical and empirical framework.
    Kibicho J; Owczarzak J
    AIDS Patient Care STDS; 2012 Jan; 26(1):20-8. PubMed ID: 22149903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.